Somatic hypermutation is the targetted process of mutagenesis which introduces single base changes into the rearranged variable regions encoding immunoglobulin heavy and light chains. Mutations are localized to the V regions of the rearranged heavy and light chain loci; promoter, leader, and constant regions do not display mutations, nor do unrearranged germ line V regions. The rate of mutation, 10-3 per base per generation, is about one million-fold higher that the typical rate of mutation in a mammalian cell. Somatic hypermutation results in the production of some B cell clones with increased affinity for antigen, thus enhancing the efficiency of the immune response. We have exciting recent results showing that gene conversion is the mechanism of somatic hypermutation of mammalian immunoglobulin genes. Our long-term goal is to understand in detail the molecular mechanism and regulation of the process of immunoglobulin gene hypermutation. Our specific experimental goals are (1) to expand the database demonstrating that gene conversion mediates somatic hypermutation: (2) to determine the molecular parameters of this process; and (3) to analyze the regulation of somatic hypermutation, asking in particular whether germinal centers are the site of hypermutation, and whether hypermutation and heavy chain class switch recombination are coordinately regulated. These experiments address the mechanism of a fundamental process in the immune response. Furthermore, since the somatic events that diversity the cellular genome during B lymphocyte development probably occur by directed use of mechanisms common to all cells, understanding the mechanism of somatic hypermutation at the immunoglobulin loci is likely to provide insight into analogous mutation events that are central to genomic evolution, genetic disease, and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM041712-02
Application #
3300058
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1989-12-01
Project End
1994-11-30
Budget Start
1990-12-05
Budget End
1991-11-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Le, Quy; Maizels, Nancy (2015) Cell Cycle Regulates Nuclear Stability of AID and Determines the Cellular Response to AID. PLoS Genet 11:e1005411
Maizels, Nancy (2013) Genome engineering with Cre-loxP. J Immunol 191:5-6
Humbert, Olivier; Davis, Luther; Maizels, Nancy (2012) Targeted gene therapies: tools, applications, optimization. Crit Rev Biochem Mol Biol 47:264-81
Yabuki, Munehisa; Cummings, W Jason; Leppard, John B et al. (2012) Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network. PLoS One 7:e36032
Sacho, Elizabeth J; Maizels, Nancy (2011) DNA repair factor MRE11/RAD50 cleaves 3'-phosphotyrosyl bonds and resects DNA to repair damage caused by topoisomerase 1 poisons. J Biol Chem 286:44945-51
Davis, Luther; Maizels, Nancy (2011) DNA nicks promote efficient and safe targeted gene correction. PLoS One 6:e23981
Eddy, Johanna; Vallur, Aarthy C; Varma, Sudir et al. (2011) G4 motifs correlate with promoter-proximal transcriptional pausing in human genes. Nucleic Acids Res 39:4975-83
Yabuki, Munehisa; Ordinario, Ellen C; Cummings, W Jason et al. (2009) E2A acts in cis in G1 phase of cell cycle to promote Ig gene diversification. J Immunol 182:408-15
Ordinario, Ellen C; Yabuki, Munehisa; Larson, Ryan P et al. (2009) Temporal regulation of Ig gene diversification revealed by single-cell imaging. J Immunol 183:4545-53
Ordinario, Ellen C; Yabuki, Munehisa; Handa, Priya et al. (2009) RAD51 paralogs promote homology-directed repair at diversifying immunoglobulin V regions. BMC Mol Biol 10:98

Showing the most recent 10 out of 30 publications